Allergan's dubious drug deal

Air Date: Sep 12, 2017 7:53 PM ET

Allergan's dubious drug deal6:50

Pharmaceutical company Allergan says it will transfer the patent to eye medication Restasis, to the Saint Regis Mohawk Tribe in a deal that Wall Street analysts call 'innovative' and tax efficient. But Bloomberg journalist Joe Nocera says it's nothing more than a "sleazy" way to block cheaper generic drugs

Markets

TSX COMPOSITE
 
Sep 26, 2017 3:45 PM ET Sep 26, 2017 3:45 PM ET Sep 26, 2017 3:45 PM ET Sep 26, 2017 3:45 PM ET Sep 26, 2017 3:45 PM ET
Index Last Trade Change
TSX COMPOSITE 15474.95 -41.28
DOW 22300.63 4.54
NASDAQ 6386.12 15.53
SP 500 2498.79 2.13
>TSX-VENTURE 776.00 -6.44

The data on this site is informational only and may be delayed; it is not intended as trading or investment advice and you should not rely on it as such.

Advertisement

Stay Connected with CBC News